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Autosomal recessive retinitis pigmentosa
E150K opsin mice exhibit
photoreceptor disorganization
Ning Zhang,1 Alexander V. Kolesnikov,2 Beata Jastrzebska,1 Debarshi Mustafi,1 Osamu Sawada,3
Tadao Maeda,1,3 Christel Genoud,4 Andreas Engel,1 Vladimir J. Kefalov,2 and Krzysztof Palczewski1
2Department

1Department of Pharmacology, School of Medicine, Case Western Reserve University (CWRU), Cleveland, Ohio, USA.
of Ophthalmology and Visual Sciences, Washington University School of Medicine, St. Louis, Missouri, USA. 3Department of Ophthalmology,
School of Medicine, CWRU, Cleveland, Ohio, USA. 4Electron Microscopy Facility, Friedrich Miescher Institute, Basel, Switzerland.

The pathophysiology of the E150K mutation in the rod opsin gene associated with autosomal recessive retinitis pigmentosa (arRP) has yet to be determined. We generated knock-in mice carrying a single nucleotide
change in exon 2 of the rod opsin gene resulting in the E150K mutation. This novel mouse model displayed
severe retinal degeneration affecting rhodopsin’s stabilization of rod outer segments (ROS). Homozygous
E150K (KK) mice exhibited early-onset retinal degeneration, with disorganized ROS structures, autofluorescent deposits in the subretinal space, and aberrant photoreceptor phagocytosis. Heterozygous (EK) mice displayed a delayed-onset milder retinal degeneration. Further, mutant receptors were mislocalized to the inner
segments and perinuclear region. Though KK mouse rods displayed markedly decreased phototransduction,
biochemical studies of the mutant rhodopsin revealed only minimally affected chromophore binding and G
protein activation. Ablation of the chromophore by crossing KK mice with mice lacking the critical visual cycle
protein LRAT slowed retinal degeneration, whereas blocking phototransduction by crossing KK mice with
GNAT1-deficient mice slightly accelerated this process. This study highlights the importance of proper higherorder organization of rhodopsin in the native tissue and provides information about the signaling properties
of this mutant rhodopsin. Additionally, these results suggest that patients heterozygous for the E150K mutation should be periodically reevaluated for delayed-onset retinal degeneration.
Introduction
Rod opsin, an apoprotein that combines with the chromophore
11-cis-retinal to form the light-sensitive visual pigment rhodopsin, is critical for visual functioning of the retina (1, 2). Rhodopsin localizes at a 5-mM concentration in specific ciliary structures
called rod outer segments (ROS) (3). This high level of protein
along with the continuous renewal of ROS (4) imposes a tremendous burden on these postmitotic photoreceptor neurons, which
in turn can affect the neighboring retinal pigmented epithelium
(RPE). Consequently, even structurally minor mutations in the
opsin gene could cause rod cell instability, aberrant signaling, or
defects in intracellular trafficking that could potentially extend
to other retinal layers and lead to a host of visually handicapping
diseases, including retinitis pigmentosa (RP).
RP is the name of a heterogeneous group of hereditary retinal
degenerative diseases that primarily affect rod photoreceptor cells
(5) (RetNet, https://sph.uth.edu/RetNet/. RP affects over 1 million individuals worldwide and an estimated 100,000 people in the
United States. Symptoms such as decreased vision under low light
and loss of peripheral visual field classified as “tunnel vision” often
first appear in childhood, but severe visual problems such as loss of
central vision do not usually develop until early adulthood. Due to
the lack of a detailed understanding of RP pathophysiology, only a
few experimental therapeutic approaches have been developed (e.g.,
refs. 6–10), with no clinically effective treatment available to date.
RP can be caused by mutations in more than 50 genes encoding
Conflict of interest: The authors have declared that no conflict of interest exists.
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photoreceptor cell proteins with an autosomal dominant (adRP),
autosomal recessive (arRP), or X-linked pattern of inheritance.
More than 100 mutations have been associated with RP in the
single gene that encodes rod opsin (11–13). Most of these mutations cause adRP, accounting for 30%–40% of the total RP cases,
whereas only a few, including severe truncation of the opsin gene
(14), are inherited in an autosomal recessive pattern. The c.448G>A
(p.E150K) mutation in patients was the first reported missense
mutation in the opsin gene associated with arRP (15, 16), and the
resulting mutant protein has since been characterized in vitro by
biochemical methods (17, 18). Another mutation that causes arRP,
G284S, is listed in RetNet, but without further biochemical characterization. Thus, it remains to be understood how missense mutations give rise to arRP in humans. Studies of RP mutations in the
opsin gene can teach us about the structure and function of this
key visual protein and the cell biology of one of the most metabolically active neurons, namely the rod photoreceptor cell.
The size of ROS has been shown to be proportional to the level
of opsin expression. Heterozygote opsin knockout mice displayed
no overt disease phenotype apart from a reduced disc diameter
(19), whereas overexpression of opsin in rods increased outer
segment diameters to accommodate the extra protein (20). Furthermore, rods from homozygous opsin-knockout mice failed to
develop outer segments (21, 22). Thus, available evidence indicates
that rhodopsin stabilizes the outer segment structure of rod cells,
in addition to its primary function in phototransduction. There
are several mechanisms potentially leading to disease in E150K
patients. The E150K mutation substituting a positively charged
Lys for the negatively charged Glu residue could result in disrup-
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Figure 1
Rhodopsin models and targeting strategy and molecular characterization of E150K knock-in mice. (A) 2D model of rhodopsin indicate residue
conservation and mutations that cause human adRP and arRP. Figure adapted with permission from Science (26). The E150K mutation is located
at the interface of the cytoplasmic side with the disc membrane, close to the putative dimerization site indicated by arrows in the (B) 3D model
of bovine rhodopsin. Figure adapted with permission from the Journal of Structural Biology (71). (C) E150K knock-in mice were generated by
using a targeting vector containing a 2.11-kb 5′ short homology arm (SA) and a 5.36 kb long homology arm (LA). A loxP-flanked Neo cassette was
upstream of exon 2. The target 284-bp sequence region included a G to A transversion at codon 150 in exon 2 (star). Codon 150 in exon 2 was
changed to AAG by homologous recombination, and the flipase recognition target loxP-flanked Neo cassette was inserted before exon 2. The Neo
cassette was removed by Cre-loxP recombination to generate E150K opsin knock-in mice. Whole-locus sequencing confirmed the knock-in (KI).
This mouse retained a 44-bp loxP sequence in the intron between exons 1 and 2. (D) PCR primers were designed to amplify the intron where
the 44-bp loxP sequence was inserted. The WT allele and E150K opsin allele produced 262- and 306-bp PCR products, respectively, whereas
the negative control displayed no template contamination. (E) Chromatogram of opsin cDNA of 2 clones from one 15-day-old EK mouse retina
confirmed the presence of both mutant and WT mRNAs.

tion of the higher-order organization of rhodopsin (19, 23–25) or
cause aberrant transport of this protein to the ROS (17, 18). Even
if the protein can properly traffic and oligomerize in rod discs, the
crystal structure of rhodopsin (26) indicates that residue 150 interacts with Arg69 in the loop connecting helices I and II (C-I loop),
and because almost the entire cytoplasmic surface of rhodopsin is
engaged in the interaction with its G protein transducin (27, 28),
122

signaling by the mutant protein could also be defective. To understand the pathophysiology of arRP, one must first have a model
for study that approximates the human condition.
Hypotheses regarding the pathophysiology of RP from previous data should be made with care, because results obtained with
cell culture systems do not always correlate with the in vivo disease state of RP. Previous studies of adRP have shown that opsin
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Table 1
cDNA ratios of E150K opsin to WT opsin reveal no significant
differences
Mouse ID
1
2
3
Total

No. of E150K clones

No. of WT clones

26
19
16
61

23
27
18
68

A total of 129 opsin cDNA clones isolated from retinas of 3 P15 EK mice
were sequenced and used to identify ratios of E150K and WT opsin to
subtotal clone numbers in each mouse. No statistically significant differences were found among E150K and WT opsin ratios.

knock-in mice can mimic the human phenotype and reveal the
pathophysiology of RP in vivo (29). Therefore, we used a gene targeting strategy to develop knock-in mice in which Glu(E)150 is
replaced by Lys(K)150. We employed multiple techniques to track
gross morphological and physiological changes in the eye to show
that this knock-in mouse model best mimics the genetic condition
affecting E150K RP patients. A set of biochemical assays involving
isolated photoreceptor membranes and purified rhodopsin from
WT and mutant mice, as well as high-resolution imaging of the
retinal layers, revealed that the degenerative phenotype of the latter is attributable to the structural destabilization of highly organized ROS disc membranes caused by E150K rhodopsin. Even in
heterozygote mice, there is diminished visual function and structural integrity with age, warranting classification of E150K as a
slowly progressing adRP rather than an arRP.
Results
EK and KK mice exhibit different rates of photoreceptor degeneration. We
generated E150K opsin knock-in mice by replacing the endogenous
opsin gene with a mouse opsin gene carrying the E150K mutation
(Figure 1, A and B). A neomycin (Neo) cassette flanked by loxP sites,
first introduced into the mouse opsin gene for clonal selection, was
later removed by electroporation with a Cre-expressing vector to
generate E150K knock-in mice. The final knock-in allele contained
the E150K mutation and one 44-bp loxP residue before exon 2 (Figure 1C). Primers flanking the loxP sequence were used for genotyping. WT mice showed a 262-bp PCR product, whereas homozygous E150K (KK) mice showed a 306-bp product; heterozygous
(EK) mice had both PCR products (Figure 1D). The entire knock-in
sequence was confirmed by direct sequencing of 9.2-kb PCR product amplified by primers located in the original mouse genome
flanking the knock-in locus (see sequencing data in the Supplement; supplemental material available online with this article;
doi:10.1172/JCI66176DS1). Sequencing cDNA from EK mice
revealed transcription of both WT and E150K mRNA (Figure 1E).
To determine the ratio of WT and E150K mRNA, we sequenced
more than 120 cDNA clones obtained from 3 mice. Numbers of
WT and E150K clones were similar, indicating that mRNA levels
for the E150K and WT opsin were comparable (Table 1).
We tracked global retinal morphologies in vivo by using spectral domain optical coherence tomography (SD-OCT). Representative 3D reconstruction of OCT images of 2-month-old mouse
retinas showed thinning of the retina indicative of photoreceptor
degeneration, especially the outer nuclear layer (ONL) in KK mice
as compared with age-matched WT mice (Figure 2A). The ONL

thickness measured from OCT images revealed the progression of
retinal degeneration in EK and KK mice (Figure 2B). Retinas from
KK mice rapidly degenerated, and their ONL almost disappeared
by 4 months of age. Retinal detachment was also evident in some
regions during OCT examination at this age (data not shown).
Surprisingly, EK mice also showed retinal degeneration, but with
a much slower time course, culminating in nearly complete loss of
ONL by 10 months of age.
Histological analyses of retinas from KK and EK mice revealed
more detailed morphological changes. At P30, the ONL consisted
of 9–10 rows of nuclei in both WT and EK mice and 7–8 rows in KK
mice. Retinal degeneration was rapid in KK mice, such that most
of the photoreceptors had disappeared by 4 months of age. At this
age, EK mice also started to lose photoreceptors, as indicated by a
decline in ONL thickness to 7–8 rows of nuclei (Figure 2C). Retinal
degeneration did not show regional variance. We cut retinal sections from 2-month-old mice from either the superior-inferior or
nasal-temporal directions across the optic nerve head. KK mice,
with only 3–4 rows of nuclei in the ONL at this age, did not show
differences in those two directions (Figure 2D). Progressive degeneration could cause poor regeneration of rod visual pigment opsin
in the mutant mice, leading to visual deterioration. To investigate
this, we studied regeneration with an analog visual chromophore to
quantify the amount of unregenerated visual pigments.
KK mice display a slight increase in free opsin accumulation. Retinal
aldehydes were derivatized with hydroxylamine, and the resulting syn- and anti-oximes were extracted from 1-month-old mouse
retinas. The amount of rhodopsin measured by the presence of
11-cis-retinal oximes in the retina was dramatically reduced in KK
mice but only modestly decreased in EK mice (Figure 3A), consistent with their differing rates of photoreceptor degeneration.
To examine the possibility that the observed retinal degeneration resulted from lower amounts of rhodopsin or the presence
of mutant opsin, we isolated retinas from WT, EK, and KK mice
and incubated them overnight in PBS alone or buffer containing 9-cis-retinal added in ethanol to prevent opsin precipitation
during detergent solubilization in the next step of the procedure
(30). 9-cis-retinal binds to free opsin in membranes forming stable
isorhodopsin, and retinoid analysis was used to determine levels
of regenerated opsin after immunoaffinity purification of rhodopsin/isorhodopsin (Figure 3). Trace amounts of 9-cis-retinal
oximes contaminated with 11,13-di-cis-retinal oxime detected in
the control samples resulted from thermal isomerization during
sample handling (Figure 3A). Substantial increases in 9-cis-retinal
oximes were detected in all regenerated retina samples compared
with control samples incubated in PBS buffer alone (Figure 3A).
Quantification of retinoids revealed a 4% greater accumulation of
9-cis-retinal in retinas isolated from the KK mutant than from WT
and EK mice (Figure 3B), indicating a small preferential accumulation of free opsin in KK mice. Similar results were obtained in two
independent experiments. To better understand the role of E150K
mutation, we purified rhodopsin from retinas of each mouse genotype to assess its folding and activation dynamics.
E150K rhodopsin is properly folded, dimerizes, and activates G protein.
Absorbance spectra of immunoaffinity-purified rhodopsin from
WT, EK, and KK mouse eyes revealed similar profiles, indicating
proper protein folding. The spectrum of rhodopsin purified from
KK mutant mice exhibited a maximum absorption peak at 498 nm
in its dark state, indicating proper formation of the Schiff base
between Lys296 of the opsin and the 11-cis-retinal chromophore.
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that E150K mutant rhodopsin
can activate Gt, and perhaps even
at a slightly higher rate than WT
rhodopsin. Because residue 150
is located in the second cytoplasmic loop on top of helix IV,
a region of rhodopsin important
for dimerization and activation
of Gt, crosslinking experiments to
measure dimerization efficiency
and the rates of Gt activation by
E150K mutant rhodopsin were
performed. Retinas isolated from
WT, EK, and KK mice were incubated with bifunctional Lys residue crosslinkers dithiobis (succinimidyl) propionate (DSP) and
disuccinimidyl glutarate (DSG)
and bi-functional Cys residue
crosslinker 3,6,9,12,15-pentaoxaheptadecane-1,17-diyl bismethanethiosulfonate (MTS).
Rhodopsin dimers and oligomers
were formed concurrently with
a decrease in the amount of rhodopsin monomer compared with
the untreated control in all WT,
EK, and KK rhodopsin samples
(Supplemental Figure 2). No differences in crosslinking properties
among the rhodopsin samples
were found, and it was also shown
Figure 2
E150K knock-in mice undergo progressive retinal degeneration. (A) Representative 3D OCT images of that the crosslinking resulted
2-month-old WT and KK retinas. Scale bar: 20 μm. The ONL was substantially thinner in retinas of KK from the chemical reaction rather
mice. (B) Thicknesses of the ONL measured 500 μm from the optic nerve head in nasal OCT images of than nonspecific aggregation.
genetically different mice as shown at various ages (n > 3). KK mice evidenced photoreceptor degenera- The biochemical consequences
tion by 1 month of age and had lost almost all their photoreceptors at the age of 4 months. (C) Plastic of these findings on visual funcsections of retinas stained with toluidine blue from WT, EK, and KK mice at 1 and 4 months of age. EK tion were then investigated using
retina displayed an intermediate progression of retinal degeneration indicated by modest degeneration various electrophysiological techby 4 months of age that progressed to nearly complete loss of photoreceptors by 10 months of age. (D)
niques to assess photoresponses
Numbers of nuclei per column in the superior-inferior and nasal-temporal axis of plastic sections crossing
the optic nerve head in genetically different mice at 2 months of age (n = 3). WT and EK mouse retinas from the whole retina as well as
exhibited virtually identical numbers of nucleated photoreceptor cells, whereas there was substantial those from isolated rods.
In vivo and ex vivo electroretinoloss of photoreceptors in KK retina. No notable regional differences in degeneration were observed in KK
retina. OPL, outer plexiform layer; INL, inner nuclear layer; IPL, inner plexiform layer.
grams reveal attenuated signals in KK
mice. In vivo electroretinogram
(ERG) recordings (Figure 4, A
Moreover, the KK rhodopsin spectra were similar to the absorbance and B, and Supplemental Figure 3A) from anesthetized 1- and
spectra of dark-state rhodopsin purified from WT and EK mice, as 2-month-old WT, EK, and KK mice revealed severely attenuated
well as following light illumination and acidification (Supplemen- scotopic responses in KK mice by 2 months of age. Photopic vision
tal Figure 1A). Indeed, consistent with proper folding, the rates of was normal at this age (Figure 4, A and B), before completely dischromophore release tested in a Meta II decay assay were similar appearing by 4 months of age (Supplemental Figure 3B). In confor WT, EK, and KK rhodopsin samples (Supplemental Figure 1B), trast, both scotopic and photopic responses appeared normal in
indicating that the E150K mutation did not perturb the activation adult EK mice at 2 months of age (Figure 4B and Supplemental
of rhodopsin. Relative fluorescence measured to determine trans- Figure 3). However, consistent with the progressive rod degeneraducin (Gt) activation rates for WT, EK, and KK rhodopsin also tion in these animals (Figure 2B), their scotopic a-wave responses
provided similar results for these three genotypes (Supplemental gradually declined with age compared with corresponding levels
Figure 1C). Interestingly, Gt activation rates were elevated slightly, in WT mice. Scotopic b-waves of EK mice also showed progressive
but significantly (P < 0.005), by 1.3-fold for E150K mutant rhodop- age-related decline, and eventually photopic b-waves were reduced
sin (KK mice) and 1.1-fold for rhodopsin from EK mice relative to as well (Supplemental Figure 3, B and C). The diminishing rates
WT rhodopsin. Biochemical characterization thus demonstrated of scotopic and photopic vision correlated well with the differing
124
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Figure 3
Regeneration of opsin with 9-cis-retinal in retinas isolated from P30 WT, EK, and KK mice. (A) Isomeric analysis of retinoid oximes (OX) is shown
for rhodopsin isolated from mouse retina incubated overnight with either 9-cis-retinal in PBS (right) or with PBS alone in a control experiment
(left). Retinoids were identified based on their UV-visible spectra and order of elution from an HPLC column as compared with authentic standards. (B) Quantification of retinoids was achieved by correlating areas under chromatographic peaks with those generated by known amounts
of synthetic standards.

time courses of rod and cone cell degeneration, which are widely
reported by many RP studies to reflect secondary cone photoreceptor degeneration after rod cell death (31, 32).
We performed ERG recordings from isolated mouse retinas to
examine rod function in mutant mice in greater detail. Transretinal ERG recordings were carried out with isolated portions of the
retina, photoreceptor side up in a recording chamber, with electrodes above and below the retina. This methodology allowed us to
record events elicited following drug application over a long period and was used to detect stable photoresponses from scarce photoreceptor populations. This approach allowed us to unmask the
overall response generated by rods by pharmacologically blocking
post-photoreceptor components of the ERG photoresponse (33).
Using this strategy, we obtained families of rod flash responses
recorded from WT, EK, and KK retinas from 3- to 5 week-old mice
(Figure 4C). Replacing one copy of WT rhodopsin with its mutant
E150K form resulted in a 21% reduction in the maximum rod
response amplitude, whereas complete substitution resulted in a
much more dramatic, 80% reduction (Figure 4, C and D). Consistent with our in vivo ERG results, the maximal amplitude of the
rod responses declined with age, and no responses were observed
in KK animals older than 6 weeks of age (data not shown). We
then fitted the corresponding normalized intensity-response relationship for each genotype with the hyperbolic Naka-Rushton
function (see Methods for details) to estimate their photosensitivity, determined as half-saturating light intensity, I1/2 (Figure 4, D
and E). Values for this parameter were essentially identical in EK
compared with WT animals, 26.8 ± 0.6 photons/μm2 (n = 9) versus

27.0 ± 0.4 photons/μm2 (n = 8), indicating normal rod sensitivity
in EK mice. Surprisingly, despite the severe degeneration of KK
rods, their normalized sensitivity was only slightly reduced, as
their I1/2 increased by only 13%, to 31.0 ± 0.6 photons/μm2 (n = 9).
This result supports the possibility that rod phototransduction
was largely unaffected by the E150K rhodopsin mutation. The
predominant fraction of chromophore-bound E150K opsin was
confirmed electrophysiologically. Treatment of dark-adapted KK
retinas with 11-cis-retinal did not increase their sensitivity relative to that of control KK retinas (Figure 4D). Thus, the level of
free opsin in their rods, if any, was too low to produce detectable
desensitization. For more refined analysis of phototransduction,
we then turned to single-cell recordings.
Phototransduction efficiency is preserved in KK mice. To discriminate
between photoreceptor degeneration and phototransduction
deficiency, we carried out single-cell suction electrode recordings
from rods of mice with differing genetic backgrounds to obtain
families of flash responses from WT, EK, and KK retinas at 3–5
month of age and analyze their properties (Figure 5A). The maximal response amplitude reflecting the size of the dark current,
Idark, was reduced by 10% in EK rods and by 41% in KK rods on
average relative to WT controls (Figure 5B and Table 2). Thus,
the reduction in the number of functional rods and the decline
in the dark current of individual cells contributed about equally
to the 20% and 80% reduction in maximal transretinal rod ERG
rod response observed in EK and KK retinas, respectively. In addition, the intensity-response curve of KK rods appeared somewhat
shallower (Figure 5C), though the mechanism producing this
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Figure 4
In vivo ERG responses and transretinal rod ERG
responses of WT, EK, and KK mice. (A) Representative full-field scotopic and photopic ERG
responses of anesthetized WT, EK, and KK mice at
2 months of age show reduced scotopic responses,
while photopic responses were still normal in KK
as compared with WT mice. Scotopic and photopic
responses were normal in EK mice. (B) Amplitudes
of rod photoreceptor cell–evoked scotopic (left)
a- and b-waves were reduced in KK mice, whereas
cone photoreceptor cell–dependent photopic (right)
a- and b-wave amplitudes were normal at 2 months
of age (n > 4). Amplitudes of a- and b-waves under
both scotopic and photopic conditions remained
unchanged in EK mice. (C) Transretinal rod ERG
responses from representative WT, EK, and KK
retinas. Flash strengths were increased stepwise
from 1.4 to 3,920 photons/μm2, by steps of 0.5 log
units each (505 nm light). Red traces of WT, EK, and
KK data represent responses to an identical light
intensity (33 photons/μm2) for comparison. In these
3 retinas, maximum responses were 185, 150, and
23 μV, respectively. Absolute (D) and normalized
(E) transretinal rod ERG response amplitudes as
a function of flash strength are shown. Points were
fitted with Naka-Rushton hyperbolic functions for
WT (n = 8), EK (n = 9), and KK (n = 9) mice. The
intensity-response relation is shown (in purple) for
KK retinas treated with 130 μM 11-cis-retinal (1 hour,
at room temperature) prior to recording (n = 4).

effect was not investigated. Notably, the normalized rod sensitivity estimated from the amplitude of dim flash responses divided
by their flash strength and normalized to the corresponding dark
current was comparable in WT, EK, and KK rods (Table 2). Consistent with the normal sensitivity of EK rods, their normalized
intensity-response curves overlapped completely with those of WT
rods (Figure 5C), and their corresponding I1/2 values were also similar (Table 2). The shallower intensity-response curve of KK rods
resulted in a slightly higher I1/2 value (Table 2), although the dim
flash section of the curve was identical to those of WT and EK rods
(Figure 5C). Together, these results demonstrate that, despite its
association with severe retinal degeneration, the mutant E150K
rhodopsin was fully functional and could activate the rod phototransduction cascade as efficiently as WT rhodopsin.
We also examined the response kinetics of mutant rods. For all
three mouse lines, we compared the averaged (cell population)
means and normalized these to their corresponding dark-current
dim flash responses. These responses were to flashes that suppressed approximately 0.2 of the total rod dark current and fell
126

within the linear range of the rod intensity-response relationship.
Notably, the activation phase of the photoresponse, indicative of
signal amplification during phototransduction, was unaffected
by the E150K mutation (Figure 5D). Rather, the expression of the
mutant rhodopsin resulted in broadening of the peak of the dim
flash response and acceleration of its shutoff. The consequent
increase in the time to peak, Tpeak, and acceleration of the recovery
time constant, τrec, were especially pronounced in KK rods (Figure
5D and Table 2). Finally, the dominant time constant of recovery
from saturating flashes, τD, was also accelerated (Figure 5E and
Table 2), suggesting accelerated transducin/phosphodiesterase
(PDE) inactivation in the mutant rods (34).
E150K rhodopsin mutant has reduced thermal stability. To determine
how the E150K mutation affects the thermal stability of rhodopsin, we measured time-dependent denaturation of rhodopsin
from WT, EK, and KK mice in isolated retinas. After 5.5 hours
of incubation at 60°C, E150K mutant rhodopsin lost approximately 81% of the chromophore, whereas rhodopsin from both
WT and EK retinas lost approximately 68% of the chromophore
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tracting the instrumental noise
measured in bright, saturating
light (Figure 6C). Mean variances
(σ2) of the dark current increased
from 0.015 ± 0.005 pA2 (n = 16)
for WT rods to 0.030 ± 0.005 pA2
(n = 16, P < 0.05) and 0.043 ± 0.005
pA2 (n = 16, P < 0.001) for EK and
KK rods, respectively. Thus, substituting E150K rhodopsin for
its WT form increased the dark
current variance 3-fold. Given the
40% reduction in dark current of
KK rods, this translates into an
8.3-fold increase in rod spontaneous phototransduction activity. The changes in dark current
might also be reflected by degenerative changes in mutant ROS.
Therefore, in spite of minor variations of physiological responses,
lack of a markedly dysfunctional
phenotype for the E150K mutant
rhodopsin suggested the pathophysiology of disease could be
driven by structural factors.
KK mice display disordered photoreceptor disc structures that disrupt
normal phagocytosis. Histological
analysis of toluidine blue–stained
retinas revealed characteristic
round-shaped and denser staining of the entire nucleus (Figure
7A, arrows), typical of pyknosis
observed in light-induced photoFigure 5
Single-cell suction electrode responses of WT, EK, and KK rods from 3- to 5-week-old mice. (A) Families receptor degeneration (35). Disorof single-cell responses from representative WT (left), EK (middle), and KK (right) rods. Flash strengths ganized photoreceptor cell outer
were increased from 0.9 to 706 photons/μm2, by single steps of 0.5 log units each (500 nm light). Red segments also were noted, which
traces show responses to the identical light intensity (20 photons/μm2) for comparison. In these 3 cells, prompted higher-resolution studdark currents were 14.2, 13.0, and 8.9 pA, respectively. Absolute (B) and normalized (C) single-cell
ies with transmission electron
response amplitudes are shown as a function of flash strength. Points were fitted with Naka-Rushton
hyperbolic functions. WT (n = 19), EK mutant (n = 19), KK mutant (n = 18) I1/2 levels are shown in Table 2. microscopy (TEM). Disorganized
(D) Normalized single-cell dim flash responses (to light intensities of 7.6 photons/μm2) from dark-adapted ROS were seen in retinas of P30
WT, EK, and KK opsin mutant rods. Phototransduction activation was unaffected, but broadening of the KK mice and could be detected
response peak and acceleration of dim flash recovery (see Table 2) were observed in KK rods, whereas as early as P14. Compared with
EK cells displayed an intermediate phenotype. (E) τD values from a series of supersaturating flashes. tightly packed discs in ROS from
Linear fits through the data yielded τD values of 385 ± 23 ms (WT, n = 19), 292 ± 24 ms (EK, n = 19), and WT and EK mice, KK mice exhib152 ± 14 ms (KK, n = 18). Recovery from saturating flashes was also accelerated in mutant photoreceptor ited disordered, loose disc archicells. Data are mean ± SEM.
tecture, as well as inclusion bodies
with thick enveloping membranes
(Figure 7B). Digestion of shed
(Figure 6A), indicating that the E150K mutant was less thermally ROS by the RPE also seemed impaired in KK mice, which, unlike
stable. Interestingly, the greatest difference in rhodopsin stabil- WT and EK mice, had undigested loose membrane structures in
ity between KK and either WT or EK retinas occurred within the their RPE cells (Figure 7C). At 4 months of age, when degeneration
first 45 minutes of incubation, with further loss proceeding at a of EK mouse retinas was evident and retinas from KK mice had
lost almost all of their photoreceptors, deposits were found in the
similar rate for all 3 rhodopsin samples.
Consistent with the reduced thermal stability of the E150K rho- subretinal spaces of EK mouse retinas, and pigmented deposits
dopsin, we also observed increased dark cellular noise in our single- were also seen in the subretinal space of KK mouse retinas. Some
cell recordings from mutant rods (Figure 6B). The greater sponta- of the deposits resembled an activated microglial cell, as a nucleus
neous phototransduction activity of mutant rods was revealed by was evident and appeared to have ingested some outer segments.
comparing the power spectra of WT and mutant rods after sub- Moreover, KK mouse retinas were devoid of photoreceptor disc
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Table 2
Parameters of single-cell suction recordings
Idark (pA)

Tpeak (ms)

Tintegr (ms)

WT (19) 14.3 ± 0.5
139.0 ± 2.1
338.8 ± 21.6
				
EK (19)
12.9 ± 0.4A
149.3 ± 2.0B
308.7 ± 21.4
			
(NS)
KK (18)
8.4 ± 0.5C
166.2 ± 5.7C
250.5 ± 10.6C
				

Sf(n) (μm2/ph)
10–2

2.6 ×
± 1.5 × 10–3
2.7 × 10–2
± 1.6 × 10–3 (NS)
2.7 × 10–2
± 2.5 × 10–3 (NS)

I1/2 (ph/μm2)

n (I1/2)

τrec (ms)

τD (ms)

26.5 ± 1.4

1.32 ± 0.02

217.8 ± 12.7

385.2 ± 23.3

27.1 ± 1.5
1.21 ± 0.03B
(NS)		
45.2 ± 6.9A
1.12 ± 0.03C

187.8 ± 15.9
(NS)
116.4 ± 7.1C

292.1 ± 24.2B
152.3 ± 13.7C

Idark is the dark current measured from light-saturated responses; time to peak (Tpeak) andintegration time (Tintegr) refer to responses with amplitudes of
approximately 0.2 Idark that fell within the linear range; Sf(n) is the normalized dim flash fractional sensitivity (amplitude of dim flash response divided by flash
strength and then normalized for the amplitude of the saturating response); I1/2 represents the half-saturating light intensity; n (I1/2) is the Hill coefficient in
the Naka-Rushton equation; τrec is the time constant representing the single-exponential decay of that dim flash response recovery phase; τD is the dominant time constant of recovery after supersaturating flashes determined from the linear fit to time in a saturation versus intensity semilog plot. Values shown
are mean ± SEM. AP < 0.05, BP < 0.01, CP < 0.001, compared with WT values.

structures at this age (Figure 7D). These structural defects could
have profound effects not only on the photoreceptors, but also on
the RPE layer, which must clear these aberrant discs by phagocytosis. Therefore, to understand the effect of E150K mutant rhodopsin, we imaged the photoreceptor-RPE interface with serial block
face scanning electron microscopy (SBF-SEM) of P14 KK mice
(36, 37). A 15-μm-thick section of KK mouse retina outside of the
optic nerve was sectioned 100 nm at a time. The resulting volume
is shown in Figure 8A, with abnormal photoreceptor inclusions
seen throughout the RPE layer highlighted in the 3D reconstruction of the RPE layer. This illustrates that this phenomenon seen
in single TEM sections is a global phenotype of the E150K retina.
Moreover, examination of the photoreceptors and the RPE cell
they contact reveals the aberrant photoreceptor morphology that
could give rise to pathological disc structures that must be processed by the RPE (Figure 8B). Structural deformities induced by
the E150K mutation leading to abnormal disc processing and subretinal deposits could cause profound changes in retinal homoeostasis that lead to immune activation. Therefore, we investigated
retinal pathology in greater detail to determine whether immune
activation could play a role in disease progression.
KK mice display rhodopsin mislocalization and retinal immune activation. Immunohistochemical staining of rod cells labeled with 1D4
antibody (38) and nuclear layers labeled with DAPI revealed that
by P30, the ROS and ONL of KK mice were shorter than those
of WT and EK mice (Figure 2, Figure 9A, and Supplemental Figure 4). Though rhodopsin normally localizes in ROS, the mutant
protein mislocalized in part to the inner segment and perinuclear
region in KK mice (Figure 9A), an observation consistent with
findings in cultured HEK293 cells (18). The decline in the photoreceptor population was unique to rods, as immunohistochemical
staining of cone cells labeled with peanut agglutinin (PNA) (35)
revealed that cone cell numbers were similar to those in retinas of
WT and EK animals (Supplemental Figure 4). Both real-time PCR
and immunoblotting experiments on rhodopsin in retinal samples
at P14, when KK mice still had the same number of rod cells as
WT mice, revealed that rod opsin did not change at the transcriptional level but instead decreased at the protein level in KK mice
(Supplemental Figure 5, A and B). This indicates that the protein
degradation machinery in rods was activated to eliminate mutant
rhodopsin. In contrast, the amount of Gtα was not affected at the
protein level in KK retina (Supplemental Figure 5B), indicating
that degraded rhodopsin had no effect on other membrane-asso128

ciated or signaling proteins. By P30, the rhodopsin content in KK
retina was about one-third that in WT or EK retina (Supplemental
Figure 5C), which quantitatively correlates with the shortening of
the ROS documented in KK mice.
Using scanning laser ophthalmoscopy (SLO) with an excitation
wavelength of 490 nm and an emission filter of 500–700 nm, we
detected autofluorescent spots in the retinal fundus of 2-monthold EK and KK mice, with many more seen in the latter (Figure
9B). Such spots were not detectable in the fundus of 1-month-old
KK mice (data not shown). Because the observation of autofluorescent spots by SLO can be attributable to possible inflammatory activation in retinas of EK and KK mice (39, 40), we used
immunohistochemistry to label and identify activated Müller cells
with glial fibrillary acidic protein (GFAP) (41, 42) and macrophage/
microglia cells with ionized Ca2+-binding adaptor molecule 1
(Iba1) (43). We found massive Müller cell activation in 1-monthold KK mouse retina, as evidenced by increased GFAP staining
(Figure 9C). In the WT retina, Iba1 labeling was seen only in the
inner retina, but in KK retina, activated macrophages/microglia
were also found in the outer segment/inner segment (OS/IS) of
photoreceptor cells (Figure 9D), indicative of immune cell migration into the subretinal space.
Genetic manipulation of key visual cycle and phototransduction proteins
highlights that the structural defect of KK mice leads to primary degeneration. Mice with a knockout of the visual cycle enzyme lecithinretinol acyltransferase (Lrat) lack 11-cis-retinal for visual pigment
regeneration, and rod cells of these mice undergo a slow degeneration, usually after 2 months of age (44, 45). We investigated photoreceptor cell survival in KK mice after genetic ablation of 11-cisretinal by cross-breeding them with Lrat–/– mice. In contrast to
KK mice, retinal degeneration was less severe in KKLrat–/– mice, as
manifested by a 2-fold increase in ONL thickness and rod photoreceptor length at 2 months of age (Figure 10, A and B). KKLrat–/–
retinas still underwent degeneration, with significantly decreased
ONL thickness compared with that of age-matched Lrat–/– mice. A
mouse with a knockout of the transducin α subunit (Gnat1), a key
component for visual phototransduction in rods, was then used
to investigate the role of phototransduction in KK rod degeneration (46). By cross-breeding Gnat1–/– with KK mice, we found that
photoreceptors degenerated faster in KK mice lacking phototransduction. The ONL thickness was 33.0 ± 2.0 μm in KKGnat1–/– and
43.3 ± 1.3 μm in KK retina based on OCT images at 1 month of
age. But the ONL thickness of Gnat1–/– mice was 58.8 ± 1.6 μm,
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Figure 6
Thermal stability of rhodopsin in retinas isolated from P30 WT, EK
and KK mice. (A) UV-visible absorbance spectra of rhodopsin in retinal membrane suspensions measured at different time points after
incubation at 60°C (0 minutes, 45 minutes, and 1.5, 2.5, 3.5, 4.5, and
5.5 hours).Thermal decay of rhodopsin was determined by plotting
the results based on 100% absorption at time 0. Error bars represent
SD values estimated from 3 independent experiments. (B) Representative current recordings from two sets of WT, EK, and KK rods in
the dark and in saturating light that closed all cGMP-gated channels.
(C) Difference power spectra (dark-light) reveal marked increases in
cellular dark noise in the 0.5- to 20-Hz frequency range in KK mice.
Data are mean ± SEM.

comparable to that of WT at this age (Figure 10, C and D). Taken
together, these results indicate that apo-E150K opsin is toxic to
rod cells, albeit less toxic than E150K rhodopsin, and the lack of
phototransduction somehow accelerates retinal degeneration in
these mutant mice. Most importantly, lack of a marked phenotypic change resulting from these genetic manipulations indicates
that although the visual cycle and phototransduction can play
a role in the retinal degeneration of E150K mice, the overriding
force driving this degenerative phenotype is likely to be the structural destabilization caused by mutated E150K rhodopsin.
Discussion
The discovery of genetic disease mutations in humans is accelerating in this age of high-throughput sequencing of both exons

and whole genomes (47). However, the proper classification of
these diseases as progressive or stationary, autosomal dominant
or autosomal recessive, and their resulting treatments require the
study of large cohorts of patients or appropriate animal models
that mimic the human condition. To this end, we generated E150K
opsin knock-in mice by replacing the endogenous opsin gene with
a mouse opsin gene carrying the E150K mutation to study the
pathophysiology of the first missense mutation associated with
arRP. Retinas of KK transgenic mice failed to develop properly, and
the ensuing retinal degeneration was rapid; almost all these photoreceptor cells had degenerated by 4 months of age. Meanwhile,
EK mice exhibited only a 20% decline in ONL length by 4 months
of age, and photoreceptor cell degeneration did not fully progress
until 10 months of age (Figure 2). The most striking phenotypic
change was that even at an early age, photoreceptor outer segments
were disorganized in KK mice (Figure 7). Disordered and loosened
discs along with formation of inclusion bodies with thick envelopes
apparently affected the RPE, where proper phagocytosis of ROS
was compromised. Moreover, the mutated protein partially mislocalized to the inner segment and perinuclear regions of the retina in
KK mice, possibly causing massive Müller cell activation indicative
of retinal stress (Figure 9). Biochemical analyses indicated that the
mutated opsin was properly folded and that chromophore binding
and Meta II decay were not affected. However, rates of Gt activation
by E150K rhodopsin were slightly elevated. Possibly because of the
disorganized structure of ROS, the accessibility of visual chromophore was affected in mutant mice such that a fraction of opsin in
dark-adapted mouse rods was increased by 4%. Interestingly, genetic elimination of chromophore production appeared to stabilize
rods (Figure 10A). In contrast, genetic ablation of phototransduction accelerated retinal degeneration (Figure 10B).
Several types of electrophysiological recordings were used to
evaluate how the E150K rhodopsin mutation affects visual function of knock-in mice. Scotopic ERG responses in vivo and from
isolated retinas evidenced severely reduced signals in KK animals,
consistent with severe retinal degeneration and disorganization
of the ROS, even when photopic vision was only slightly affected.
Moreover, both scotopic and photopic ERG signals declined as the
degeneration progressed. But because normalized sensitivity was
only slightly reduced, we believe that rod phototransduction was
largely unaffected by the E150K rhodopsin mutation, an interpretation supported by single-cell response recordings (Figure 5). The
lack of proper structural organization and reduced volume of ROS
could accelerate transducin/PDE inactivation in mutant rods,
because recovery from both dim and saturating flashes was also
accelerated (Figure 5, D and E). Based on our biochemical data,
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Figure 7
Photoreceptor and RPE structures in WT, EK, and KK mice. (A) Plastic sections of P30 KK mouse retinas stained with toluidine blue show disorganized photoreceptor OS with dying photoreceptor cells (arrows). Scale bar: 20 μm. (B) TEM images depict disordered photoreceptor OS
discs in P30 KK mouse retina but not in retinas from WT or EK littermates. In WT and EK retinas, higher-magnification images reveal normal
ROS architecture, whereas in the KK retina, there is severe ROS disorganization characterized by ROS with loosened and irregular shaped discs
together with inclusions (arrows). Scale bars: 1 μm. (C) Phagosomes in P14 WT, EK, and KK RPE. Normal phagosomes were observed in P14
WT and EK mouse RPE (boxes with dashed lines in the upper two rows; scale bar: 4 μm). Augmented phagosome images are shown in right
panels. Scale bar, 1 μm. P14 KK mouse retinas display severe RPE pathology with undigested phagocytized discs (arrows, bottom panels) and
even ingested discs show abnormal processing. (D) TEM images of retinas from 4-month-old WT, EK, and KK mice. Compared with WT retinas,
EK retinas exhibit largely normal-appearing discs in most regions of the outer segment, with just a few abnormal deposits (*) in the subretinal
space. KK mouse retinas completely lacked photoreceptor disc structures at this age (&) but pigmented deposits (#) are seen in their subretinal
space. Scale bar: 5 μm. IS, photoreceptor inner segment.

the E150K mutant was less thermally stable, resulting in increased
dark cellular noise in vivo (Figure 6) and an estimated 8.3-fold
increase in rod spontaneous phototransduction activity.
Four major conclusions can be derived from the above evaluations of retinal structure and function in KK and EK mice. The
first involves the disease classification of EK mutant mice, in
which retinal pathology and functional decline progressed with
age. This is reminiscent of fundus albipunctatus caused by muta130

tions in the RDH5 gene and Oguchi disease involving mutations
in arrestin and rhodopsin kinase that initially were considered
stationary diseases in their homozygous forms. However, with
better imaging and physiological measurements, both these
diseases were found to be slowly progressive in terms of retinal
degeneration and visual dysfunction because they emanated from
mutations encoding key proteins of the visual cycle and phototransduction (48–50). These results along with the current study
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Figure 8
SBF-SEM highlights global pathological effects of the
E150K mutation on photoreceptors and the RPE of the P14
KK retina. (A) SBF-SEM was carried out involving 100-nm
serial sections of a 15-μm-deep volume of the KK retina. A
3D representation of the retina (abnormal disc inclusions
in the RPE are indicated by yellow arrows) is shown in the
upper part, with resulting reconstructions of the RPE cells
depicted in different colors and abnormal disc inclusions
inside the cell denoted by brown-filled volumes shown in
the lower part. The center RPE cell has a characteristic
hexagonal shape shown in more detail in B, where different
areas of that reconstructed RPE cell (gray, nucleus in blue)
highlight representative abnormal disc inclusions indicated
in the raw SEM image by yellow arrow. Abnormal photoreceptor packing (photoreceptors in green with the abnormal 1 colored red) is also seen in the raw SEM image with
the abnormal photoreceptor indicated by a yellow asterisk.
Scale bars: 1 μm.

demonstrate that E150K retinopathy could similarly be properly
classified as slowly progressing adRP. Thus, patients heterozygous
for the E150K mutation should be encouraged to have their retinal structure and function periodically reevaluated and treatment
options appropriately adjusted when they become available.
Second, these E150K opsin mutant mice reveal much about
the structure and organization of the ROS. Rhodopsin is essential for ROS formation; its lack does not allow formation of ROS
from embryonic rod cells (21, 22). Increased or decreased expression of rhodopsin produces altered ROS sizes proportional to the
amount of rhodopsin synthesized (19, 20). Moreover, disorganization of ROS in mice with a positively charged residue in the
E150K mutant contributes to disruption of the previously proposed higher-order organization of rhodopsin (19, 23–25). This
interpretation is compatible with results indicating that lack of a
sufficient amount of rhodopsin due to aberrant transport would
affect the size of ROS but not their structure, and thus would not
cause ROS degeneration. But the E150K rhodopsin mutant also
disrupts electrostatic interactions because of the substitution of a
positively charged Lys for the negatively charged Glu residue. This
in turn can lead to a different oligomeric structure documented
by crosslinking of rhodopsin that does not support formation of
ROS. This abnormal structure is manifested by altered biochemical properties, electrophysiological responses, abnormal internal
disc structure, and aberrant shedding of ROS membranes.
Third, these mice provide information about the signaling properties of this mutant rhodopsin. Previous studies in cell culture
systems showed that the E150K mutation caused accumulation
of positive charges on the cytoplasmic surface of rhodopsin (17,
18). Here, we demonstrate that mouse rods expressing E150K rhodopsin undergo severe and rapid retinal degeneration. As a result,
the rod-driven light responses from EK and KK retinas declined by
20% and 80%, respectively. Comparison of the response declines
measured by transretinal and single-cell recordings indicated
that a reduction in the number of functional rods and a decline
in the dark current of individual rods contributed about equally
to the overall reduction in rod-generated responses. Surprisingly,
despite the severe degeneration of mutant rods, their normalized

light sensitivity was essentially unaffected (Figures 4 and 5). Moreover, as demonstrated by the identical rising phases of their dim
flash responses, amplification of the phototransduction cascade
was normal in rods expressing the mutant rhodopsin (Figure
5D). Thus, despite the disruption of electrostatic interactions and
the severe retinal degeneration induced by this mutation, E150K
rhodopsin could effectively trigger the phototransduction cascade. This conclusion is supported by our direct measurements of
transducin activation (Supplemental Figure 1C) showing that the
E150K mutation not only failed to inhibit the activation of transducin but, in fact, even slightly enhanced it. Thus, we conclude
that the E150K mutation does not affect the signaling properties
of rhodopsin and the reduced function observed is due solely to
mutant rod degeneration. Also seemingly related to ROS disorganization is the somewhat faster response shutoff observed in
mutant rods (Figure 5, D and E), indicative of their accelerated
transducin/PDE inactivation.
The slight increase in the apoprotein opsin fraction in independent experiments (Figure 3B) did not appear to reduce the dim
flash sensitivity of mutant rods (Figure 4E). One possible explanation is that the activity of E150K opsin might be lower than that of
WT opsin, thus producing a minimal activation of the phototransduction cascade in the mutant rods. However, a more likely scenario is that this increased opsin fraction is too small to reduce the
sensitivity of mutant rods, as treatment of KK retinas with endogenous 11-cis-retinal failed to increase their sensitivity (Figure 4D).
A physiologically relevant change in the properties of this
mutant opsin was a reduction in its thermal stability (Figure 6A).
Consistent with this result, we also observed a 3-fold increase in
cellular noise exhibited by mutant KK rods (Figure 6, B and C),
indicating an 8.3-fold increase in rod spontaneous phototransduction activity. However, it is currently unclear what fraction of this
increase was due to the increased spontaneous activation of E150K
rhodopsin and what fraction, if any, was due to changes in basal
phototransduction activity associated with the degenerative morphological changes in the ROS.
Finally, the E150K mouse opsin mutant displayed differences
in stability after genetically induced ablation of the visual cycle
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Figure 9
Rhodopsin mislocalization, fundus autofluorescent spots,
and Müller/macrophage/microglial cell activation in retinas
of KK mice. (A) E150K rhodopsin probed with 1D4 antibody
mislocalized in part to the inner segment and perinuclear
region of 1-month-old mouse retina. In contrast, rhodopsin
localized normally within the ROS of WT and EK retina. (B)
SLO fundus images from WT, EK, and KK mice at 2 months
of age. Numerous autofluorescent spots are evenly distributed throughout the KK mouse fundus, whereas autofluorescence is barely visible in WT fundus. EK fundus exhibited a
moderate fluorescent phenotype. (C) Immunohistochemistry
of 1-month-old WT, EK, and KK mouse retinas with GFAP
antibody that labels activated Müller cells. Massive activation
of Müller cells is evident in KK but not in WT or EK retina. (D)
Immunohistochemical analysis of 1-month-old WT, EK, and
KK mouse retinas with Iba1 antibody (green) used to mark
macrophage or microglia. In WT and EK retinas, Iba1 immunoreactivity was observed only in the ganglion cell layer
(GCL) to the OPL, whereas in KK retina, Iba1 labeling also
localized to the outer photoreceptor cell layer (arrows). DAPI
was used to counterstain nuclei. All immunohistochemistry
was done with retinas from 1-month-old mice. Scale bars:
40 μm. IS, photoreceptor inner segment.

of phototransduction that have potential implications for the
treatment of retinal diseases. We genetically eliminated the retinoid cycle, the process that regenerates the light-sensitive chromophore 11-cis-retinal (51, 52). In contrast to adRP-causing opsin
gene mutations P23H (29) and T4R (18, 53), the E150K mutant
opsin appears more stable under such conditions, inducing a
milder retinal disease phenotype than these counterparts. This
could be attributed to the profound oligomerization of opsin versus rhodopsin that could preferentially benefit the E150K mutant
ROS. In contrast, ablation of phototransduction accomplished
by genetic removal of the Gtα (54) slightly accelerated degeneration of E150K retina. Although we do not yet understand why this
occurs, a reasonable speculation favors an ion flow imbalance in
a highly compromised ROS structure. Our genetic results suggest
that, in contrast to other models of RP, exposure to moderate light
could be beneficial. Moreover, higher expression of WT rhodopsin
in E150K mutant mice with stabilization of the oligomeric rhodopsin structure could also improve ROS stability. In conclusion,
this work highlights the importance of generating proper animal
models of even rare variants of RP to study their pathophysiology
in vivo and emphasizes that a structural abnormality (in oligomer132

ization of rhodopsin resulting in abnormal assembly of the ROS)
is the primary defect induced by the E150K mutation.
Methods
Animals. E150K knock-in mice used in this study were generated by inGenious Targeting Laboratories. C57BL/6J WT mice (Jackson Laboratory)
were used for crossbreeding with E150K mice. Lrat–/– (44, 55) and Gnat1–/–
mice (54) also were employed for crossbreeding experiments. Lack of rd/rd
and rd8 mutations in these animals was verified by using published
methods (56, 57). Mice were routinely maintained in a 12-hour light (<10
lux)/12-hour dark cycle, with ad libitum access to food and water.
Chemicals and antibodies. 11-cis-retinal was a gift from R. Crouch (University of South Carolina School of Medicine, Columbia, South Carolina, USA),
and 9-cis-retinal was purchased from Toronto Research Chemical. DSP and
DSG were purchased from Thermo Scientific. MTS was purchased from
Santa Cruz Biotechnology Inc.
1D4 mouse mAb was obtained from R. Molday (University of British
Columbia, Victoria, British Columbia, Canada) (58) (5 mg/ml; 1:100,000
dilution for immunoblotting, 1:10,000 for immunohistochemistry);
B6-30 mAb was a gift from P. Hargrave (University of Florida, Gainesville, Florida, USA) (59) (1 mg/ml; 1:4,000 for immunoblotting, 1:400
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Figure 10
Effects of genetic depletion of 11-cis-retinal
production or absence of rod phototransduction on retinal degeneration in KK mice. (A)
Plastic sections of retinas crossing the optic
nerve head of 2-month-old KK and KKLrat–/–
mice. Sections were stained with toluidine
blue (upper panels). KKLrat–/– retina showed
increased number of rows of photoreceptor cell
nuclei as compared with age-matched KK retina. This finding is consistent with the increased
thickness of the ONL in KKLrat–/– retina shown
in the corresponding SD-OCT images (lower
panels). (B) Thickness of the ONL in KK,
KKLrat–/–, and Lrat–/– mice measured at 500
μm from the optic nerve head of nasal OCT
images (n > 3). Depletion of 11-cis-retinal partially protected against retinal degeneration in
KK mice. (C) SD-OCT images of retinas crossing the optic nerve head from 1-month-old KK
and KKGnat1–/– mice. KKGnat1–/– retina displayed decreased thickness of ONL relative
to an age-matched KK retina. (D) Thickness of
the ONL in KK, KKGnat1–/–, and Gnat1–/– mice
measured 500 μm from the optic nerve head
in nasal OCT images (n > 3). Absence of the
Gtα caused greater retinal degeneration in KK
mice. *P < 0.05, **P < 0.01. Scale bars: 20 μm.

for immunohistochemistry); biotinylated PNA was purchased from Vector Laboratories (1:400 for immunohistochemistry); rabbit anti-GFAP
polyclonal antibody (pAb) was from Dako (1:400 for immunohisto
chemistry); rabbit anti-Iba1 pAb was obtained from Wako (1:400 for
immunohistochemistry); sc389 anti-Gαt1 pAb was purchased from Santa
Cruz Biotechnology Inc. (1:5,000 for immunoblotting); and AC-15 anti–
β-actin mAb was purchased from Abcam (1:5,000 for immunoblotting).
Generation of E150K knock-in mice. E150K knock-in mice were generated
as follows: a 7.75-kb region used to construct the targeting vector was first
subcloned from a positively identified C57BL/6 (RP23: 88A11) BAC clone.
As shown in Figure 1C, the construct was designed as follows: the short
homology arm (SA) extended about 2.11 kb 5′ to a loxP-flanked Neo cassette inserted 183 bp upstream of exon 2; the target region of 284 bp contained the loxP-Neo cassette and exon 2 with a point mutation engineered
by overlap extension PCR to introduce a G>A mutation that caused a Glu
to Lys residue alteration in codon 150; and the long homology arm (LA) of
5.36 kb then was located 3′ to exon 2. This BAC construct was subcloned
into an approximately 2.4-kb backbone vector (pSP72, Promega) containing an ampicillin selection cassette for transformation of the construct
prior to electroporation. The targeting vector was linearized by NotI and
then transfected by electroporation into iTL BA1 (C57BL/6 × 129/SvEv)
hybrid ES cells. After selection with G418 antibiotic (Sigma-Aldrich), surviving clones were expanded for PCR analysis to identify recombinant ES
clones. Clone 734, confirmed as correctly targeted, was then electroporated
with a Cre-expressing vector to eliminate the Neo cassette. Electroporated
clones were grown in G418-free medium. After targeted hybrid ES cells
from Neo-deleted clone 181 were microinjected into C57BL/6 blastocysts,
the resulting chimeric mice with a high percentage of agouti coat color

were mated with WT C57BL/6 mice to generate F1 heterozygous founders.
Three founders and their offspring were then identified by PCR of their
genomic DNA obtained from tail biopsies with a forward primer (NDEL1,
5′-AGGCTGACATATGGACTAATGTCTGG-3′) and a reverse primer
(NDEL2, 5′-GCTAGGATGCAAGCTTCTGGTTTG-3′) (Figure 1D).
Opsin locus sequencing. A approximately 1-cm tail snip from an F2 homozygous E150K mouse was incubated overnight at 55°C with 20 mg/ml proteinase K (Fisher Scientific) in 500 μl proteinase K buffer (50 mM Tris, 100
mM NaCl, 10 mM EDTA, 1% SDS, pH 8.0). Initially, 250 μl of supersaturated NaCl was added to each sample to solubilize proteins. Then 250 μl
chloroform was added as an organic layer. After shaking and centrifugation, a supernatant was obtained that contained genomic DNA. One milliliter of cold 100% ethanol was added to genomic DNA precipitated from
500 μl supernatant. The precipitated DNA was rinsed twice with 70% ethanol and then dissolved in nuclease-free water. The opsin locus, including
the entire targeted region, was amplified by using Takara LA Taq DNA
polymerase (Takara) with the primers A4, 5′-GTCTCCATAGCCCATGGTCATCCCTC-3′ and B4, 5′-AGGCAGGAGTAAAGATGACACCCCAC-3′.
Resulting amplified PCR products (8.3 kb) were gel purified and sequenced
with DNA sequencing primers at approximately 700-bp intervals.
Opsin cDNA fragment cloning. Retinas from EK mice at P15 were dissolved
in 400 μl TRI Reagent (Applied Biosystems). Total RNA, extracted according to the manufacturer’s instructions, was dissolved in 50 μl RNase-free
water, and contaminating genomic DNA was removed by RNase-free
DNase RQ1 (Promega). cDNA was synthesized with the Power SYBR Green
PCR Master Mix (Applied Biosystems) according to the manufacturer’s
instructions. The same amount of total RNA was processed without reverse
transcriptase as a negative control. PCR was performed by using GoTaq
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Flexi DNA polymerase (Promega) with primers Rho-cDNA-F2, 5′-CTTCGGAGGATTCACCACCACCC-3′ and Rho-cDNA-R2, 5′-CAATCCCGCATGAACATTGCATGCC-3′. The 308-bp predicted PCR products were not
generated by negative controls involving either non-reverse-transcribed
total RNA or water as templates (data not shown). After purification by
a Wizard SV gel and PCR clean-up system (Promega), PCR products were
ligated into pGEM-T Easy vector (Promega) and transfected into JM109
cells (Promega). Sequencing was used to determine the presence of WT
and E150K opsin fragments; examples of sequence chromatograms from
mouse ID L1R1 are shown in Figure 1E. To assess the ratio between E150K
and WT opsin mRNA, we sequenced 129 cDNA clones from 3 EK mice and
calculated the WT to E150K opsin cDNA ratios (Table 1).
Ultra-high-resolution SD-OCT and SLO imaging. For all in vivo imaging, mice
were anesthetized by intraperitoneal injection of a cocktail (10 μl/g body
weight) containing ketamine (10 mg/ml) and xylazine (0.4 mg/ml) in PBS
(HyClone Laboratories). Pupils were dilated with 1% tropicamide (Bausch
and Lomb). Ultra-high-resolution SD-OCT (Bioptigen) was employed
for imaging (60). Four pictures acquired in the B-scan mode were used to
construct each final averaged 2D SD-OCT image, and the rectangular volume scan mode was used to construct 3D images. The Heidelberg Retinal
Angiograph II (Heidelberg Engineering) was employed for SLO imaging.
Immunohistochemistry. Mouse eye cups were fixed with 4% paraformal
dehyde in 0.1 M sodium phosphate buffer (pH 7.4) for 2 hours at 4°C.
Fixed tissues were dehydrated with 30% sucrose in PBS, embedded in
O.C.T. sucrose mixture (1:1 O.C.T./30% sucrose in PBS), and then frozen
as described previously (61). Cryosections (12 μm thick) were cut with a
cryostat-microtome (CM1850, Leica); incubated with primary antibodies
1D4, PNA, GFAP, or Iba1 (see Chemicals and antibodies for more information); and visualized with anti-mouse, goat anti-rabbit Alexa Fluor 488– or
Cy3–conjugated IgGs (1:500, Jackson ImmunoResearch Laboratories Inc.)
or Alexa Fluor 488–conjugated streptavidin (1:500, Invitrogen). Fluorescence was detected with a fluorescence microscope (CTR 6000, Leica).
Images captured with a CCD camera (Retiga EXi Fast 1394, QImaging)
were analyzed with Adobe Photoshop software.
Immunoblotting. Retinas from both eyes of a mouse were homogenized in ice-cold RIPA buffer (150 mM NaCl, 1.0% NP-40, 0.5% sodium
deoxycholate, 0.1% SDS, and 50 mM Tris, pH 8.0) with protease inhibitors
(Sigma-Aldrich). Protein concentrations were measured with a Pierce BCA
assay kit (Thermo Scientific). Protein (15 μg) from each sample was transferred to immunoblot-PVDF membranes for SDS-PAGE gel electrophoresis. Primary antibodies identical to those used for immunohistochemistry
were detected by incubation with goat anti-rabbit or anti-mouse secondary
antibodies conjugated with horseradish peroxidase (1:2,000). Anti–β-actin
(AC-15, Abcam) was employed for the loading control.
Real-time (RT)-PCR. Total RNA from mouse retinas was isolated with
TRI Reagent (Applied Biosystems), and possible contaminating genomic
DNA was removed by RNase-free DNase I (Promega). Total RNA (1 μg)
was reverse transcribed with a high-capacity cDNA reverse transcription
kit (Applied Biosystems) in a total volume of 20 μl. Then 0.5% of this reaction mixture was used as a template for a RT-PCR reaction with Taqman
Gene Expression Assays (Applied Biosystems) following the manufacturer’s instructions. Mm00520345_m1 was used to probe rhodopsin, with
the 18S rRNA (4319413E) probe set (Applied BioSystems) employed as an
endogenous control. All real-time experiments were done with the Applied
BioSystems Step-One Plus RT-PCR machine.
Histology: light and transmission electron microscopy. Mouse eyecups were first
fixed overnight by immersion in 5% glutaraldehyde/4% paraformaldehyde,
pH 7.4, at 4°C. Then they were washed with 0.13 M sodium phosphate, pH
7.3, and secondarily fixed with 1% OsO4 in 0.1 M sodium phosphate, pH 7.4,
for 2 hours at room temperature. Eye cups subsequently were dehydrated
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through an ethanol series (50%, 70%, 80%, 90%, 95%, and 100%), transitioned to epoxy embedding medium with propylene oxide, and embedded
for sectioning in Eponate 812. Sections for morphological study were cut
at 1 μm with a microtome (Leica RM2255) and stained with toluidine blue.
Digital images were captured with a Leica DMI 6000 B inverted microscope.
For EM studies, ultrathin sections (70 nm) were prepared with an ultramicrotome (Reichert-Jung Ultracut E), stained with uranyl acetate, and
adsorbed onto carbon grids. A Tecnai T12 electron microscope (FEI) operating at 120 kV or 200 kV with a LaB6 filament was used for final imaging.
SBF-SEM, data analysis, and 3D reconstructions. Blocks prepared for TEM
were used for SBF-SEM. The sample was prepared and cut using a Quanta
200 (FEI) with Gatan 3View software as described previously (37). Serial
sectioning was performed on the block face by cutting a 100-nm slice from
the face with a diamond knife and imaging the freshly cut block from the
backscattered electron signal. This process was automated to collect 200
successive images over approximately 12 hours. Imaging was performed at
an accelerated voltage of 3 kV in a low-vacuum mode (0.23 Torr) at 4,096by 4,096-pixel resolution, with a pixel size of 17 nm.
After serial sectioning, images were viewed with Fiji-win32 (a version of
ImageJ) and merged to form a stack. The stack was registered and aligned
to account for drift that could have occurred during the experiment. The
registered stack was then opened using the Reconstruct program (62), and
structural elements were mapped to provide 3D reconstructions.
Purification of rhodopsin from mouse eyes. Eyes from two 4-week-old darkadapted WT, EK, and KK mice were collected and used immediately for
rhodopsin purification or stored at –80°C. Eyes were homogenized with a
hand-held glass homogenizer in 2 ml buffer composed of 20 mM Bis-Tris
propane (BTP), pH 7.5, 150 mM NaCl, 1 mM EDTA, and protease inhibitors. The homogenate was centrifuged at 25,000 g in a benchtop centrifuge
for 15 minutes at 4°C. The supernatant was discarded, and the pellet was
suspended in buffer composed of 20 mM BTP, pH 7.5, 150 mM NaCl, and
20 mM n-dodecyl-β-d-maltoside (DDM) (Affymetrix) and incubated at
room temperature for 1 hour. The sample then was centrifuged at 100,000 g
for 45 minutes at 4°C. The supernatant was incubated with 0.5 ml of 1D4
immunoaffinity resin equilibrated with buffer composed of 20 mM BTP,
pH 7.5, 150 mM NaCl, and 2 mM DDM for 1 hour at room temperature.
This resin was loaded into a column and washed with 10 ml of the above
buffer. Rhodopsin then was eluted from the column with equilibrating
buffer supplemented with 800 μM 1D4 peptide (TETSQVAPA). The absorbance spectrum of purified rhodopsin was obtained with a Cary50 UVvisible spectrophotometer. The concentration of rhodopsin was calculated
by measuring the absorbance at 500 nm and using a molar extinction coefficient of 40,600 M–1cm–1 (63). Rhodopsin photoactivation was achieved
by illuminating samples for 5 minutes with a Fiber-Lite illuminator (Dolan
Jenner Industries) through a 480–520 nm band-pass filter.
Meta II decay. Meta II decay rate determinations were performed according to a tryptophan fluorescence method described previously (64). All
measurements were done with 30 nM rhodopsin dissolved in buffer consisting of 20 mM BTP, pH 6.0, 100 mM NaCl, and 1 mM DDM which
favors formation of Meta II, the activated form of rhodopsin. Rhodopsin
was bleached for 15 seconds with a 150-W Fiber-Lite illuminator through
a 480–520 nm band-pass filter. Intrinsic tryptophan fluorescence was then
immediately monitored with a PerkinElmer LS 55 fluorescence spectrophotometer at an excitation wavelength of 295 nm (2.5-nm slit) and an
emission wavelength of 330 nm (5-nm slit). The temperature of the cuvette
was maintained at 20°C with a circulating water bath. The increase in tryptophan fluorescence correlated with the release of all-trans-retinal from the
binding pocket of rhodopsin. Fluorescence data were analyzed with SigmaPlot (Systat Software Inc.) by nonlinear regression fitting to an equation
describing first-order reaction kinetics to obtain the time constant τ.
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Gt activation. The functionality of rhodopsin purified from mouse retinas
was evaluated by a Gt activation fluorescence assay. The molar ratio of Gt to
Rho was 10:1 at concentrations of 250 nM and 25 nM, respectively. Protein
samples were diluted in 20 mM BTP buffer, pH 7.0, containing 120 mM
NaCl, 2 mM MgCl2 and 1 mM DDM and then exposed to light for 15 seconds with a Fiber-Lite covered with a band-pass wavelength filter (480–520
nm). The reaction was carried out at 20°C in a continuously stirred cuvette.
After 300 seconds of incubation, 5 M GTPγS was added. The intrinsic
increase in fluorescence emanating from Gαt was measured with a PerkinElmer LS55 luminescence spectrophotometer employing excitation and
emission wavelengths of 300 and 345 nm, respectively (65, 66). No changes
in tryptophan fluorescence were detected in control experiments without
GTPγS. A pseudo-first-order kinetic rate constant (k) was derived from the
following function: A(t) = Amax(1 – exp–kt), where Amax is the maximal Gαt
fluorescence change and A(t) is the relative fluorescence change at time t.
Opsin regeneration with 9-cis-retinal and retinoid analyses. Retinas were isolated
from dark-adapted WT, EK, and KK mice, and each retina was incubated
with 50 μM 9-cis-retinal in 200 μl PBS overnight in the dark on ice. The
next day, the PBS buffer with excess 9-cis-retinal was discarded, and retinas
were suspended in buffer composed of 20 mM BTP, pH 7.5, containing
150 mM NaCl and protease inhibitors and homogenized with an Eppendorf homogenizer. This solution was supplemented with 20 mM DDM
and incubated for 1 hour on ice to solubilize membranes. Samples were
centrifuged at 100,000 g for 45 minutes. Collected supernatants were
incubated with 250 μl 1D4-immunoaffinity resin pre-equilibrated with
20 mM BTP, pH 7.5, 150 mM NaCl, and 2 mM DDM for 1 hour at room
temperature. Then the resin was loaded into a column and washed extensively with 25 ml of the above buffer. To separate retinoids from rhodopsin bound to the 1D4 resin, protein was first denatured for 30 minutes
with 50% CH3OH in the presence of 40 mM NH2OH. The resulting retinal oximes were extracted with 600 μl hexane, and their isomeric content
was determined by normal-phase HPLC with an Ultrasphere-Si, 5 μm,
4.5 × 250 mm column (Beckman). Retinoids, eluted isocratically with
10% ethyl acetate in hexane at a flow rate of 2 ml/min, were detected by
absorption at 360 nm. These were quantified by correlating areas under
their chromatographic peaks with those generated from known amounts
of synthetic standards.
Thermal stability of rhodopsin. The thermal stability of rhodopsin was measured in retinas isolated from WT, EK and KK mice. Four to 10 retinas
were suspended in 1.6 ml buffer composed of 20 mM BTP, pH 7.4, and
100 mM NaCl; homogenized with an Eppendorf homogenizer on ice;
and then centrifuged at 1,000 g for 2 minutes at 4°C to remove unhomogenized tissue. The resulting membrane suspension was placed in an
incubator at 60°C. Then at 0 minutes, 45 minutes, 1.5 hours, 2.5 hours,
3.5 hours, 4.5 hours, and 5.5 hours, 200-μl aliquots were collected and
quickly solubilized with 20 mM DDM, and their absorbance was recorded.
Resulting absorbance values at 500 nm were employed to create a plot
of rhodopsin’s thermal decay. Standard deviations were calculated from
3 sets of experimental data.
Chemical crosslinking of rhodopsin. Crosslinking reactions of rhodopsin were
performed with retinas isolated from WT, EK, and KK mice. Retinas were
washed twice in the crosslinking buffer composed of 100 mM Na2HPO4,
pH 8.3, containing 150 mM NaCl, and then single retinas were gently
homogenized in 200 μl of the same buffer. Unhomogenized tissue was
removed by brief centrifugation at 1,000 g for 2 minutes. The homobifunctional Lys residue crosslinkers DSP and DSG were solubilized in DMSO to
a final concentration of 50 mM (stock solutions) and then diluted ×50 to
achieve a 1-mM concentration (~400 fold molar excess) in the crosslinking
reaction. Crosslinking reactions were performed for 1 hour on ice and terminated by adding 1 M Tris/HCl, pH 7.5, to a final concentration of 100 mM.

The MTS Cys residue bifunctional crosslinker was solubilized in DMSO
to a final concentration of 25 mM (stock solution) and diluted ×62.5 to
a final concentration of 400 μM in the crosslinking reaction. This reaction was carried out for 1 hour on ice and then quenched by adding 0.5 M
N-ethylmaleimide to a final concentration of 20 mM. In control samples,
the DSP and MTS samples were treated with 100 mM DTT after crosslinking to cleave the disulfide linkages. The resulting crosslinking of rhodopsin
was checked by immunoblotting with anti-rhodopsin B6-30 antibody.
Mouse ERGs. All ERG procedures were performed according to published
methods (67). For single-flash recording, the duration of white-light flash
stimuli (from 20 μs to 1 ms) was adjusted to provide a range of illumination intensities (from –3.7 to 1.6 log cd×s/m2). Three to 5 recordings
were made at sufficient intervals between flash stimuli (from 3 seconds to
1 minute) to allow recovery from any photobleaching effects.
Transretinal ERG recordings. Three- to 5-week-old WT, EK, and KK mice
were dark-adapted overnight and sacrificed by CO2 asphyxiation, and their
retinas were removed under infrared illumination and stored in oxygenated aqueous L15 (13.6 mg/ml, pH 7.4, Sigma-Aldrich) solution containing
0.1% BSA at room temperature. A single retina was mounted on filter paper
with the photoreceptor side up and placed on the recording chamber with
an electrode connected to the bottom of the perfusion chamber. A second
electrode was placed just above the center of the retina, which was perfused
with Locke’s solution (112.5 mM NaCl, 3.6 mM KCl, 2.4 mM MgCl 2,
1.2 mM CaCl2, 10 mM HEPES, pH 7.4, 20 mM NaHCO3, 3 mM Na succinate, 0.5 mM Na glutamate, 0.02 mM EDTA, and 10 mM glucose). This
solution was supplemented with 2 mM l-glutamate and 10 μM DL-AP-4 to
block higher-order components of the photoresponse (68); 20 μM BaCl2 to
suppress the glial component (69); and MEM vitamin and amino acid solutions (Sigma-Aldrich) to retain retinal viability. The perfusion solution was
continuously bubbled with a 95% O2/5% CO2 mixture heated to 36–37°C.
The solution in the lower electrode compartment (140 mM NaCl, 3.6 mM
KCl, 2.4 mM MgCl2, 1.2 mM CaCl2, 3 mM HEPES, 10 mM glucose, pH 7.4)
also contained 2 mM l-glutamate and 10 mM BaCl2.
Light stimulation was applied as 20-ms test flashes of calibrated 505-nm
LED light. For light uniformity, a glass optical diffuser was placed between
the LED and the retina. The stimulating light intensity was controlled by
neutral density filters and a computer in 0.5 log unit steps. Photoresponses
were amplified by a differential amplifier (DP-311; Warner Instruments),
low-pass filtered at 30 Hz (8-pole Bessel), digitized at 1 kHz, and stored in
a computer for further analysis. The intensity-response relationships for
both single-cell and transretinal recordings were fitted with Naka-Rushton
hyperbolic functions, as follows:

		
(Equation 1)
for fitting absolute data, or

		
(Equation 2)
for fitting normalized data — where R is the transient-peak amplitude of
response, Rmax is the maximal response amplitude, I is the flash intensity, n is
the Hill coefficient (exponent), and I1/2 is the half-saturating light intensity.
Single-cell suction recordings. Three- to 5-week-old WT, EK and KK mice
were dark-adapted overnight and sacrificed by CO2 asphyxiation, and their
retinas were removed under infrared illumination, chopped into small
pieces, and transferred to a perfusion chamber located on the stage of an
inverted microscope. Then a single ROS was drawn into a glass microelectrode filled with a solution containing 140 mM NaCl, 3.6 mM KCl, 2.4 mM
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MgCl2, 1.2 mM CaCl2, 3 mM HEPES, pH 7.4, 0.02 mM EDTA, and 10 mM
glucose. The perfusion Locke’s solution (see previous section) was bubbled
with a 95% O2/5% CO2 mixture and heated to 37–38°C.
Light stimuli were applied in 20-ms test flashes of calibrated 500-nm
light. Photoresponses were amplified, low-pass filtered (30 Hz, 8-pole Bessel), and digitized (1 kHz). Normalized dim flash fractional sensitivity
(Sf(n)) was calculated from the linear region of the intensity-response curve
as the ratio of the response amplitude to flash strength and then normalized by the amplitude of the saturating response. I1/2 was calculated from
the intensity-response relationship as the test flash intensity required to
produce a response with an amplitude equal to half of the corresponding
saturated response amplitude. Integration time (Tintegr) was calculated as
the integral of the dim flash response with the transient peak amplitude
normalized to unity. The time constant for the dim flash response recovery
(τrec) was derived from the best single-exponential fit to the declining phase
of the response. The dominant recovery time constant (τD) was determined
from supersaturating flashes (70), by using a 10% criterion for photocurrent recovery from saturation. Data were analyzed with Clampfit 10.2
(Molecular Devices) and Origin 8.5 software (OriginLab).
Statistics. Data representing the mean ± SEM (unless otherwise mentioned) are presented for the results of at least 3 independent experiments
compared by 2-tailed Student’s t test. Differences with P values less than
0.05 were considered statistically significant.
Study approval. All animal procedures and experiments were approved by
the CWRU and the Washington University Animal Care Committees and
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